Page 9 - Accurium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Curium Acquires Austrian Radiopharmaceuticals Company IASON May 31, 2021 22:00 ET | Source: Curium Curium Paris, FRANCE Paris, May 31, 2021 (GLOBE NEWSWIRE) -- (Graz and Paris – June 1st, 2021) —Curium has successfully completed the acquisition of the Austrian radiopharmaceuticals Company IASON, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions. This is the second acquisition of a positron-emission-tomography (PET) radiopharmaceutical business by Curium this year after the acquisition of M2i...

Investegate announcements from Curium, Curium Acquires Austrian Radiopharmaceuticals Company IASON

St. Louis, MO, May 05, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that Detectnet is now included in the National Comprehensive Cancer Network (NCCN) Clinical

(0) St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the U.S. Food and Drug Administration (FDA). Curium has been granted priority review by the FDA, which has set a Generic Drug User Fee Act (GDUFA) goal date in Q4 2021. Ioflupane I 123 Injection is a single-photon emission computed tomography (SPECT) brain imaging agent used to assist in the evaluation of adult patients with suspected Parkinsonian syndromes. "Curium is committed to developing generic...

Eckert & Ziegler's GalliaPharm distributed by Curium in France Berlin, Germany and Paris, France, March 01, 2021 (GLOBE NEWSWIRE) -- Eckert & Ziegler Radiopharma GmbH and Curium PET France have decided to reinforce their existing long term partnership by extending their agreement for the distribution of Galliapharm generators in France, Curium being the partner of choice given the national coverage of its PET network in France . "Achieving greater market penetration for our core product GalliaPharm is the focus of our sales strategy. With its established network in France, Curium is thus ...